Medical Oncology

Thalassemia

Questions discussed in this category

What is your strategy for optimizing hydroxyurea dosage in patients with symptomatic sickle cell disease, particularly for genotypes HbSS and HbS/Beta thal?

1 Answer available

Papers discussed in this category

The New England journal of medicine, 2008-03-27

Hydroxyurea for the treatment of sickle cell anemia.

The New England journal of medicine, 2020 Jun 25

Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa.

Frontiers in genetics, 2022 Aug 26

Barriers to hydroxyurea use from the perspectives of providers, individuals with sickle cell disease, and families: Report from a U.S. regional collaborative.

Related Topics in Medical Oncology